• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性非息肉病性结直肠癌的妇科筛查

Gynecologic screening in hereditary nonpolyposis colorectal cancer.

作者信息

Rijcken Fleur E M, Mourits Marian J E, Kleibeuker Jan H, Hollema Harry, van der Zee Ate G J

机构信息

Department of Gastroenterology, University Hospital Groningen, Groningen, The Netherlands.

出版信息

Gynecol Oncol. 2003 Oct;91(1):74-80. doi: 10.1016/s0090-8258(03)00371-8.

DOI:10.1016/s0090-8258(03)00371-8
PMID:14529665
Abstract

OBJECTIVE

In hereditary nonpolyposis colorectal cancer (HNPCC), women with a mismatch repair (MMR) gene mutation have a cumulative lifetime risk of 25-50% for endometrial cancer and 8-12% for ovarian cancer. Therefore, female members of HNPCC families are offered an annual gynecologic and transvaginal ultrasound (TVU) examination and serum level CA 125 analysis. The aim of the present study was to evaluate our 10-year experience with this screening program.

METHODS

Women who are MMR gene mutation carriers or who fulfil the Amsterdam criteria were identified from our HNPCC database. Information concerning the screening program was retrospectively collected from patient files.

RESULTS

Forty-one women, 35 premenopausal and 6 postmenopausal, were enrolled in the program with a median follow-up of 5 years (range 5 months-11 years). In 197 patient years at risk, 17 of 179 TVUs gave reason for endometrial sampling. Three premalignant lesions, with complex atypical hyperplasia, were discovered. One interval endometrial cancer was detected as a result of clinical symptoms. No abnormal CA 125 levels were measured and no ovarian cancers were detected.

CONCLUSIONS

These results demonstrate that gynecologic screening allows the detection of premalignant lesions of the endometrium but also illustrate that recognition and reporting of clinical symptoms by the women themselves is of utmost importance.

摘要

目的

在遗传性非息肉病性结直肠癌(HNPCC)中,错配修复(MMR)基因突变的女性患子宫内膜癌的终生累积风险为25% - 50%,患卵巢癌的风险为8% - 12%。因此,HNPCC家族的女性成员每年接受妇科检查、经阴道超声(TVU)检查以及血清CA 125水平分析。本研究的目的是评估我们在这一筛查项目中的10年经验。

方法

从我们的HNPCC数据库中识别出MMR基因突变携带者或符合阿姆斯特丹标准的女性。有关筛查项目的信息从患者档案中进行回顾性收集。

结果

41名女性纳入该项目,其中35名处于绝经前,6名处于绝经后,中位随访时间为5年(范围5个月 - 11年)。在197个患者年的风险期内,179次经阴道超声检查中有17次提示需要进行子宫内膜取样。发现3例伴有复杂非典型增生的癌前病变。因临床症状检测出1例间隔期子宫内膜癌。未检测到CA 125水平异常,也未发现卵巢癌。

结论

这些结果表明,妇科筛查能够检测出子宫内膜的癌前病变,但也说明女性自身对临床症状的识别和报告至关重要。

相似文献

1
Gynecologic screening in hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌的妇科筛查
Gynecol Oncol. 2003 Oct;91(1):74-80. doi: 10.1016/s0090-8258(03)00371-8.
2
A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families.针对遗传性非息肉病性结直肠癌(林奇综合征)家族女性的妇科癌症监测的系统评价。
Acta Obstet Gynecol Scand. 2011 May;90(5):437-44. doi: 10.1111/j.1600-0412.2011.01091.x. Epub 2011 Mar 16.
3
The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌家系的妇科监测结果。
Gynecol Oncol. 2014 Jun;133(3):526-30. doi: 10.1016/j.ygyno.2014.03.012. Epub 2014 Mar 13.
4
Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families.遗传性非息肉病性结直肠癌家族中女性对妇科监测的认识。
Fam Cancer. 2006;5(4):405-9. doi: 10.1007/s10689-006-0012-x. Epub 2006 Aug 26.
5
Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.林奇综合征/遗传性非息肉病性结直肠癌家族中的妇科癌症预防
Obstet Gynecol. 2007 Jul;110(1):18-25. doi: 10.1097/01.AOG.0000267500.27329.85.
6
Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.有遗传性非息肉病性结直肠癌风险的年轻女性的癌症风险:对妇科监测的影响
Gynecol Oncol. 2001 Mar;80(3):346-9. doi: 10.1006/gyno.2000.6065.
7
Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.对于林奇综合征女性,子宫内膜活检联合经阴道超声检查优于单独经阴道超声检查用于子宫内膜监测。
Fam Cancer. 2009;8(4):391-7. doi: 10.1007/s10689-009-9252-x. Epub 2009 Jun 6.
8
Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome.超声检查对遗传性非息肉病性结直肠癌/林奇综合征患者子宫内膜癌筛查的作用。
Int J Gynecol Cancer. 2010 May;20(4):583-7. doi: 10.1111/IGC.0b013e3181d7283a.
9
Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.遗传性非息肉病性结直肠癌的妇科表现。从遗传性疾病到散发性疾病。
Oncology (Williston Park). 2006 Jan;20(1):85-94; discussion 94-6, 100.
10
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.遗传性非息肉病性结直肠癌:诊断策略及其影响。
Evid Rep Technol Assess (Full Rep). 2007 May(150):1-180.

引用本文的文献

1
Lynch Syndrome-Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches.林奇综合征——错配修复基因缺陷型突变类型对诊断、临床表现、监测及治疗方法的影响
Medicina (Kaunas). 2025 Jan 14;61(1):120. doi: 10.3390/medicina61010120.
2
Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands.林奇综合征患者子宫内膜癌预防策略的结局:荷兰一项全国性队列研究
EClinicalMedicine. 2024 Dec 21;79:103006. doi: 10.1016/j.eclinm.2024.103006. eCollection 2025 Jan.
3
Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation.
林奇综合征女性的妇科癌症监测:系统评价和成本效益评估。
Health Technol Assess. 2024 Aug;28(41):1-228. doi: 10.3310/VBXX6307.
4
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.林奇综合征中子宫内膜癌或卵巢癌的筛查和降低风险手术:系统评价。
Int J Gynecol Cancer. 2022 May 3;32(5):646-655. doi: 10.1136/ijgc-2021-003132.
5
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.日本结直肠癌学会(JSCCR)2020年遗传性结直肠癌临床实践指南。
Int J Clin Oncol. 2021 Aug;26(8):1353-1419. doi: 10.1007/s10147-021-01881-4. Epub 2021 Jun 29.
6
Recent advances in Lynch syndrome.林奇综合征的最新进展
Exp Hematol Oncol. 2021 Jun 12;10(1):37. doi: 10.1186/s40164-021-00231-4.
7
Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers.荷兰林奇综合征携带者的妇科监测与手术结果
Cancers (Basel). 2021 Jan 26;13(3):459. doi: 10.3390/cancers13030459.
8
Genetics and the Gynecologic Patient.遗传学与妇科患者
Ochsner J. 2020 Winter;20(4):446-451. doi: 10.31486/toj.20.0051.
9
Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management.子宫内膜癌的遗传易感性:风险因素与临床管理
Cancers (Basel). 2020 Aug 25;12(9):2407. doi: 10.3390/cancers12092407.
10
Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome.林奇综合征患者经阴道填塞取样的可行性。
BMC Womens Health. 2020 Mar 17;20(1):54. doi: 10.1186/s12905-020-00920-y.